<DOC>
	<DOCNO>NCT02057861</DOCNO>
	<brief_summary>In study investigator aim compare time antagonism intensity effect sugammadex use antagonism rocuronium diabetic non-diabetic patient .</brief_summary>
	<brief_title>Reversal Neuromuscular Blockade Diabetic Patients</brief_title>
	<detailed_description>Aim : In study investigator aim compare time antagonism intensity effect sugammadex use antagonism rocuronium diabetic non-diabetic patient . Methods : Included patient divide 2 group : diabetic ( n=21 ) non-diabetic ( n=20 ) . All patient premedicated . After arrival operating room , patient monitorised Datex Ohmeda S/5 Anesthesia Machine electrocardiography ( DII derivation ) , hemodynamic variable , respiratory rate , inspiratory sevoflurane concentration record . Neuromuscular monitoring system use . Anesthesia induce propofol 2 mg/kg fentanyl 1 mcg/kg . After loss eyelid reflex neuromuscular monitoring system automatically identify supramaximal stimulate current rocuronium 0,6 mg/kg give . Train four ( TOF ) stimulation supramaximal current apply record second TOF value ( TOF2 ) patient intubate . Anesthesia maintain 50 % O2 + 50 % air sevoflurane 1-2 % concentration . TOF stimulation apply record every 20 second . Intraoperatively return T2 rocuronium 0,15 mg/kg give . T2i time record intubation time T2d time record clinical effect time . At end operation sugammadex 2 mg/kg give . When TOF rate reach 0,9 patient extubated time record .</detailed_description>
	<criteria>The patient ( diabetic nondiabetic ) 1865 year risk anesthesia III , For diabetic group patient Diabetes mellitus Type 2 10 year . For nondiabetic group patient without glucose metabolism disease myasthenia gravis , myotonic dystrophia , motor neuron diseases diabetic neuropathy nephropathy hepatic , renal cardiac disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>diabetes mellitus</keyword>
	<keyword>neuromuscular blockade</keyword>
	<keyword>sugammadex</keyword>
</DOC>